Novel inhibitors of human IDO1 and TDO

被引：1
|
作者：
Banerjee, Monali
Middya, Sandip
Shrivastava, Ritesh
Raina, Sushil
Yadav, Dharmendra
Singh, Satveer
Manna, Anindita
Chakraborty, Debjani
Surya, Arjun
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2015年 / 3卷 / 10期
关键词：
D O I：
10.1158/2326-6074.TUMIMM14-A59
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A59
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Discovery of IDO1 Inhibitors: From Bench to Bedside
    Prendergast, George C.
    Malachowski, William P.
    DuHadaway, James B.
    Muller, Alexander J.
    CANCER RESEARCH, 2017, 77 (24) : 6795 - 6811
  • [32] 基于靶标IDO1、TDO的抑制剂研究进展
    董俊敏
    刘站柱
    药学学报, 2021, 56 (05) : 1265 - 1278
  • [33] Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay
    de Iudicibus, Rossella Capochiani
    Tomek, Petr
    Palmer, Brian D.
    Tijono, Sofian M.
    Flanagan, Jack U.
    Ching, Lai-Ming
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 39
  • [34] Discovery and optimization of substituted oxalamides as novel heme-displacing IDO1 inhibitors
    Steeneck, Christoph
    Kinzel, Olaf
    Anderhub, Simon
    Hornberger, Martin
    Pinto, Sheena
    Morschhaeuser, Barbara
    Albers, Michael
    Sonnek, Christina
    Czekanska, Marta
    Hoffmann, Thomas
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 33
  • [35] Synthesis and in vivo antitumor evaluation of an orally active potent phosphonamidate derivative targeting IDO1/IDO2/TDO
    Feng, Xi
    Shen, Pei
    Wang, Yinuo
    Li, Zhiyu
    Bian, Jinlei
    BIOCHEMICAL PHARMACOLOGY, 2019, 168 : 214 - 223
  • [36] A theoretical study on the activity and selectivity of IDO/TDO inhibitors
    Wujieti, Baerlike
    Feng, Xinping
    Liu, Erxia
    Li, Deqing
    Hao, Mingtian
    Zhou, Luqi
    Cui, Wei
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2024, 26 (23) : 16747 - 16764
  • [37] GS-4361: A novel IDO1 Inhibitor
    Kalla, Rao
    Elbel, Kristy
    Bartlett, Mark
    Cosman, Jennifer
    Perry, Thao
    Elzein, Elfatih
    Li, Xiaofen
    Koltun, Dmitry
    Parkhill, Eric
    Zablocki, Jeff
    Clark, Mike
    Maecker, Heather
    Jawahar, Sudhamsu
    Hendricks, Deborah
    Shornikov, Alex
    Koditek, David
    Stafford, Brian
    Soohoo, Daniel
    Voigt, Johannes
    Lansdon, Eric
    Mackman, Richard
    Corkey, Britton
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [38] Discovery of novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors by virtual screening
    Zhou, Yeheng
    Peng, Jiale
    Li, Penghua
    Du, Haibo
    Li, Yaping
    Li, Yingying
    Zhang, Li
    Sun, Wei
    Liu, Xingyong
    Zuo, Zhili
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019, 78 : 306 - 316
  • [39] Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities
    Cheong, Jae Eun
    Sun, Lijun
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2018, 39 (03) : 307 - 325
  • [40] Synthesis and activity study of novel N,N-diphenylurea derivatives as IDO1 inhibitors
    Hou, Xi-Xi
    Wu, Zi-Yuan
    Zhan, An
    Gao, En
    Mao, Long-Fei
    Wang, Hui-Li
    Yang, Jian-Xue
    FRONTIERS IN CHEMISTRY, 2023, 11
12345